Clinical trial
Phase II Study of SOX in Patients With Platinum-resistant Nasopharyngeal Carcinoma
NCT01403259 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase II Study of SOX in Patients With Platinum-resistant Nasopharyngeal Carcinoma
- Lead sponsor
- Fudan University
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- July 31, 2011
- Completion date
- December 31, 2015
- Enrollment
- 16 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.